Cora Capital Advisors LLC Astrazeneca PLC Transaction History
Cora Capital Advisors LLC
- $194 Billion
- Q2 2024
A detailed history of Cora Capital Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cora Capital Advisors LLC holds 4,184 shares of AZN stock, worth $324,134. This represents 0.17% of its overall portfolio holdings.
Number of Shares
4,184
Previous 4,186
0.05%
Holding current value
$324,134
Previous $284 Million
15.06%
% of portfolio
0.17%
Previous 0.15%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,334Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.03 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.3 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.14 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.84 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.36 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...